Stay updated with breaking news from Revascularization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cwm LLC trimmed its stake in Penumbra, Inc. (NYSE:PEN – Free Report) by 9.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,680 shares of the company’s stock after selling 170 shares during the period. Cwm LLC’s holdings in Penumbra were worth $468,000 […]
Penumbra, Inc. (NYSE:PEN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month target price among brokerages […]
Robert W. Baird initiated coverage on shares of Penumbra (NYSE:PEN – Free Report) in a report released on Tuesday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $375.00 price target on the stock. Other analysts also recently issued reports about the stock. Needham & Company LLC downgraded shares of Penumbra from a […]
Penumbra (NYSE:PEN – Free Report) had its target price upped by BTIG Research from $328.00 to $351.00 in a research report sent to investors on Monday, FlyOnTheWall reports. PEN has been the subject of several other reports. Deutsche Bank Aktiengesellschaft boosted their price target on Penumbra from $325.00 to $376.00 in a report on Monday, […]
F M Investments LLC purchased a new stake in Penumbra, Inc. (NYSE:PEN – Free Report) during the first quarter, according to its most recent filing with the SEC. The firm purchased 7,065 shares of the company’s stock, valued at approximately $1,969,000. Penumbra accounts for approximately 2.0% of F M Investments LLC’s portfolio, making the stock […]